Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Evening Primrose Oil: The Definitive Guide

Evening primrose oil is a variable source of gamma-linolenic acid. Trial schedules are condition-specific and do not establish one routine dose.

Form, active amount, population and outcome stay connected.
Published by DoserlyUpdated Next scheduled review: January 20276 min readHow this guide was made
In this guide

What is Evening Primrose Oil?

Evening primrose oil is a variable source of gamma-linolenic acid. Trial schedules are condition-specific and do not establish one routine dose. No U.S. DRI or established daily requirement exists for evening primrose oil or supplemental GLA. [1]

Typical Evening Primrose Oil Protocols

Research schedules and references only; these are not prescriptions.
Source and populationForm and amount each timeFrequencyTotal exposureDuration or boundary
Kumari 2024 · 126 premenopausal women with cyclical mastalgiaEvening primrose oil 1,000 mg per administrationTwice daily2,000 mg oil/day; GLA not reported in abstract6 months; factorial arms included vitamin E
Gholami 2025 · painful diabetic neuropathyEvening primrose oil 1,000 mg per administrationOnce daily or every 12 hours1,000 or 2,000 mg oil/day4 weeks; small three-group trial
Mastalgia synthesis 2021Various EPO productsStudy-specificNo universal GLA dose13 trials; 1,752 randomized participants

These rows reproduce sources. Do not average them into one universal regimen.

Source, active amount and outcome stay attached. Sources: Official source · Human study.

Which forms and label details matter?

Record oil mass and declared GLA separately. Different oils can supply different GLA per capsule; co-administered vitamin E changes the intervention.

How should it be stored?

Follow the label, close the container and protect it from heat, light and moisture.

Product mass and active amounts are not interchangeable. Sources: Official monograph.

What is it commonly used for?

Common claims include cyclical breast pain, neuropathic pain, eczema and menopausal symptoms. Results are mixed, often small and condition-specific.

What does human research show?

A 2021 review of 13 trials and 1,752 randomized participants found no meaningful advantage for evening primrose oil over placebo, topical NSAIDs, danazol or vitamin E for mastalgia. [2] Kumari later randomized 126 premenopausal women for six months; EPO 1,000 mg twice daily, vitamin E 400 mg once daily, and their combination improved pain, with the combination performing best. Because the intervention combined ingredients and the report has design/reporting limits, it does not overturn the broader monotherapy synthesis. [3] Gholami’s small 2025 neuropathy study compared 1,000 mg daily with 1,000 mg every 12 hours and mixed placebo schedules for four weeks; positive pain-score changes need replication and do not replace standard diabetes and neuropathy care. [4] NCCIH reports insufficient evidence for most promoted uses; oral EPO and borage oil do not meaningfully improve eczema in pooled evidence. [1]

Conceptual illustration of a normal heart and artery.
Simplified normal cardiovascular anatomy; this illustration does not demonstrate a supplement benefit.

How might it act?

Fatty acids enter membranes, serve as energy substrates or act as precursors to mediators according to their structure. This mechanism does not turn a blood-level change into prevention of a clinical event.

How does it compare with related products?

ProductWhat the label needs to statePractical distinction
Fish oilEPA, DHA and total oilMarine EPA+DHA mixture; findings from an EPA-only prescription drug do not automatically transfer.
Krill oilEPA, DHA, phospholipids and shellfish sourceDifferent source with a shellfish allergen; total oil mass does not reveal EPA+DHA mass.
Algal oilDHA, any EPA and total oilNon-fish source; formulations can be mainly DHA.
Cod liver oilEPA, DHA, vitamin A and vitamin DAdds fat-soluble vitamins that must be counted with other products.

What are the risks and interactions?

GI upset and headache can occur. Review pregnancy, breastfeeding, bleeding risk, anticoagulants, antiplatelets, surgery and seizure history or medicines that lower seizure threshold. Do not substitute it for breast, neuropathy or skin evaluation.

Which medicines require review?

Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.

Common questions about Evening Primrose Oil

Does evening primrose oil treat breast pain?

The pooled evidence found no clear advantage; one later combination trial does not establish EPO monotherapy.

Does it treat diabetic neuropathy?

A small four-week trial was positive, but confirmation and standard care remain necessary.

Does it treat eczema?

Pooled oral EPO and borage evidence does not show meaningful benefit.

Is 1,000 mg a GLA dose?

No. It usually refers to oil mass; read the declared GLA separately.

Can it be used in pregnancy?

Do not infer safety from retail availability; obtain obstetric review.

What should I track?

Oil and GLA per administration, frequency, co-ingredients, pain scale, adverse effects and review date.

Glossary

Terms for reading the evidence.

ALA
Essential 18-carbon omega-3; adult AIs refer to this form.
EPA
Long-chain omega-3; distinct from total oil weight.
DHA
Long-chain omega-3; often present in a different amount from EPA.
Amount per administration
Amount consumed at one time, distinct from daily total.
Biomarqueur
Biological measure that is not necessarily a clinical benefit.
UL
Tolerable Upper Intake Level established for a nutrient and defined scope.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources

Sources preserve form, amount, frequency, population, duration and outcome.

Showing 6 sources

  1. 01

    Evening Primrose Oil: Usefulness and Safety ↗

    Official evidence and safety overview

    Current page or report reviewed; scope and limits retained.

    Detail: Evidence limits, eczema synthesis and safety cautions.

  2. 02

    A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment. ↗

    Systematic review and meta-analysis

    Current page or report reviewed; scope and limits retained.

    Detail: 13 trials and 1,752 randomized participants; no clear comparative pain advantage.

  3. 03

    Effectiveness of Evening Primrose and Vitamin E for Cyclical Mastalgia: A Prospective Study. ↗

    Randomized combination trial

    Current page or report reviewed; scope and limits retained.

    Detail: 126 women; EPO 1,000 mg twice daily, vitamin E 400 mg daily, combination or placebo for six months.

  4. 04

    Effects of evening primrose oil on treating painful diabetic neuropathy: a randomized, double-blind, clinical trial. ↗

    Small randomized clinical trial

    Current page or report reviewed; scope and limits retained.

    Detail: Daily versus every-12-hour 1,000 mg administrations over four weeks; small mixed-placebo design.

  5. 05

    Questions and Answers on Dietary Supplements ↗

    U.S. regulatory overview

    Current page or report reviewed; scope and limits retained.

    Detail: Supplements generally lack efficacy preapproval.

  6. 06

    Product Licensing ↗

    Canadian licensing overview

    Current page or report reviewed; scope and limits retained.

    Detail: Finished natural health products require licensing and authorized labels.